BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 21592430)

  • 1. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
    Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
    Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.
    Brotherton JM; Liu B; Donovan B; Kaldor JM; Saville M
    Vaccine; 2014 Jan; 32(5):592-7. PubMed ID: 24316239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis.
    Wang H; Qiao YL
    Int J STD AIDS; 2008 Oct; 19(10):680-4. PubMed ID: 18824620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 9. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.
    Brotherton J; Gertig D; Chappell G; Rowlands L; Saville M
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):197-201. PubMed ID: 22010515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination.
    Cooper Robbins SC; Bernard D; McCaffery K; Brotherton J; Garland S; Skinner SR
    Vaccine; 2010 Apr; 28(19):3398-408. PubMed ID: 20199758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators.
    Barbaro B; Brotherton JM
    Aust N Z J Public Health; 2015 Aug; 39(4):326-30. PubMed ID: 26094817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM; Kaldor JM; Garland SM
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Australian experience with the human papillomavirus vaccine.
    Garland SM
    Clin Ther; 2014 Jan; 36(1):17-23. PubMed ID: 24417782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.